Back to results
US 2017/0321189 A1Published application
Co-Differentiation Of Monocytes From Allogeneic Donors
AssigneeImmunicum AB
InventorsAlex KARLSSON-PARRA, Bengt ANDERSSON
Life of this patent
Estimating the term…
Abstract
Disclosed is a method of producing non-exhausted immature dendritic cells (DCs) originating front at two different, allogeneic donors. In the method, a mixture of allogeneic leukocytes, which allogeneic leukocytes have been obtained from at least two different, allogeneie donors is provided. Subsequently, allogeneic monocytes are isolated from the mixture of allogeneic leukocytes. Thereafter, non-exhausted immature DCs are generated from said isolated allogeneic monocytes.
Claims20
A method of producing pro-inflammatory dendritic cells (DCs), comprising the steps of:
- providing a mixture of allogeneic leukocytes, which allogeneic leukocytes have been obtained from at least two different, allogeneic donors;
- isolating allogeneic monocytes from said mixture of allogeneic leukocytes to provide monocyte-enriched allogeneic leukocytes;
- generating non-exhausted immature DCs from said monocyte-enriched allogeneic leukocytes, wherein the generation of non-exhausted immature dendritic cells (DCs) is performed by co-culturing said monocyte-enriched allogeneic leukocytes for 2 to 7 days in aqueous cell culture medium free from non-human serum, said medium being supplemented with interleukin-4 (IL-4) and granulocyte-macrophage colony stimulating factor (GM-CSF);
- and
- activating the non-exhausted immature DCs to obtain pro-inflammatory DCs.
2 more elements
(canceled)
(canceled)
Dependencies are inferred from the claim text.